Physician profile
Stacy Suzanne Brown
NPI 1366880908
$3,043.99
in general payments reported to CMS, 2019-2025
34 companies · $639 in 2025
The $639 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $225 · 2021: $227 · 2022: $392 · 2023: $557 · 2024: $590 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $751.83 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $285.25 | 2019-2025 | Myosure Tissue Removal Device |
| Organon LLC | $226.50 | 2021-2025 | Nexplanon, Jada System |
| Coopersurgical, INC. | $183.77 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Novo Nordisk INC | $155.30 | 2025 | Wegovy |
| Sumitomo Pharma America, INC. | $154.70 | 2024-2025 | Myfembree, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Enhertu |
| Medtronic, INC. | $109.88 | 2022 | |
| Exeltis, USA INC. | $96.91 | 2022-2023 | Slynd |
| Biogen, INC. | $93.24 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $90.17 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $84.54 | 2022-2025 | Veozah |
| Merck Sharp & Dohme LLC | $82.73 | 2019-2024 | Gardasil, Gardasil 9 |
| Vertex Pharmaceuticals Incorporated | $44.34 | 2025 | |
| Millicent US INC | $43.56 | 2024-2025 | Femring, Intrarosa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $41.20 | 2021-2024 | Twirla |
| 180 Medical, INC. | $39.67 | 2019-2024 | Gentlecath |
| Mayne Pharma Commercial LLC | $39.61 | 2024 | |
| Shionogi INC | $33.33 | 2019 | |
| Heron Therapeutics, INC. | $32.16 | 2023 | Zynrelef |
| Aspira Women'S Health INC | $32.12 | 2020 | |
| Therapeuticsmd, INC. | $29.20 | 2019-2021 | |
| Myovant Sciences INC. | $28.84 | 2021 | |
| Pfizer INC. | $28.76 | 2025 | |
| Dynavax Technologies Corporation | $28.66 | 2024 | Heplisav-B |
| Bluewind Medical | $26.59 | 2025 | Revi |
| Pacira Pharmaceuticals Incorporated | $24.87 | 2025 | Exparel |
| Dysis Medical, INC. | $24.80 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.49 | 2024 | Caplyta |
| Ethicon US, LLC | $19.59 | 2021 | |
| Daiichi Sankyo INC. | $19.32 | 2020 | |
| Convatec INC. | $16.70 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.61 | 2019 | |
| Minerva Surgical, INC | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.